Anthony S. Chilton

67 year

Consumer Services

Commercial Services

Health Technology

Profile

Anthony S.
Chilton served as President, Chief Executive Officer & Director at Inotiv, Inc. from 2011 to 2012.
Prior to that, he was VP-Biopharmaceutical Development Division at Cardinal Health, Inc. and Vice President-PreClinical Development at Genmedica Therapeutics SL.
Chilton received his undergraduate degree from the University of East Anglia in 1981 and his doctorate from the University of Hertfordshire in 1993.

Former positions of Anthony S. Chilton

Companies	Position	End
INOTIV, INC.	President	05/07/2012
CARDINAL HEALTH, INC.	Corporate Officer/Principal	-
Genmedica Therapeutics SL Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain.	Corporate Officer/Principal	-

See the detail of Anthony S. Chilton's experience

Training of Anthony S. Chilton

University of East Anglia	Undergraduate Degree
University of Hertfordshire	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anthony S. Chilton's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
INOTIV, INC.	Commercial Services
CARDINAL HEALTH, INC.	Distribution Services

Private companies	1
Genmedica Therapeutics SL Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain.	Health Technology